Stevanato Group (NYSE:STVN) Given New $32.00 Price Target at KeyCorp

Stevanato Group (NYSE:STVN) had its price target lowered by equities research analysts at KeyCorp from $37.00 to $32.00 in a research report issued to clients and investors on Thursday, MarketBeat Ratings reports. The firm currently has an “overweight” rating on the stock.

Several other equities research analysts have also issued reports on STVN. Wall Street Zen lowered shares of Stevanato Group from a “buy” rating to a “hold” rating in a report on Saturday, February 14th. Jefferies Financial Group set a $17.50 price objective on shares of Stevanato Group in a research note on Tuesday, February 10th. Weiss Ratings restated a “hold (c)” rating on shares of Stevanato Group in a research report on Monday, December 29th. Finally, Morgan Stanley started coverage on Stevanato Group in a research note on Monday, December 1st. They set an “equal weight” rating and a $24.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Stevanato Group presently has a consensus rating of “Moderate Buy”.

Stevanato Group Trading Down 8.5%

NYSE:STVN traded down €1.49 during midday trading on Thursday, hitting €16.01. 194,477 shares of the company traded hands, compared to its average volume of 736,905. The firm has a market capitalization of $4.85 billion, a P/E ratio of 28.18, a P/E/G ratio of 1.18 and a beta of 0.57. The firm’s fifty day moving average is €17.79 and its 200-day moving average is €21.75. Stevanato Group has a 12-month low of €13.91 and a 12-month high of €28.00. The company has a current ratio of 1.89, a quick ratio of 1.30 and a debt-to-equity ratio of 0.26.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. T. Rowe Price Investment Management Inc. raised its position in Stevanato Group by 10.4% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 3,923,632 shares of the company’s stock valued at $78,944,000 after purchasing an additional 368,792 shares in the last quarter. Susquehanna Portfolio Strategies LLC increased its stake in shares of Stevanato Group by 62.8% during the fourth quarter. Susquehanna Portfolio Strategies LLC now owns 72,554 shares of the company’s stock valued at $1,460,000 after buying an additional 27,991 shares during the period. Millennium Management LLC purchased a new position in shares of Stevanato Group during the fourth quarter valued at $278,000. Balyasny Asset Management L.P. raised its holdings in shares of Stevanato Group by 688.3% in the fourth quarter. Balyasny Asset Management L.P. now owns 112,253 shares of the company’s stock valued at $2,259,000 after acquiring an additional 98,013 shares in the last quarter. Finally, Bamco Inc. NY lifted its stake in Stevanato Group by 1.4% in the fourth quarter. Bamco Inc. NY now owns 2,001,724 shares of the company’s stock worth $40,275,000 after acquiring an additional 27,965 shares during the period.

Key Headlines Impacting Stevanato Group

Here are the key news stories impacting Stevanato Group this week:

• Positive Sentiment: Company set a 2026 revenue target up to €1.308 billion and expects high‑value solutions to reach ~48% of sales — a shift toward higher‑margin products that supports revenue growth and margin expansion. Stevanato Group outlines 2026 revenue target up to €1.308B with high-value solutions set to reach 48% of sales
• Positive Sentiment: Full‑year 2025 revenue grew 7% (9% at constant currency) with record revenue from high‑value solutions and expanded margins — evidence that the product mix transition is already contributing to results. Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025
• Positive Sentiment: Market reaction was strong after the quarter — reports show the stock surged following the Q4 release as investors rewarded top‑line growth and the high‑value narrative. Stevanato Group surges nearly 17% on fourth quarter earnings beat
• Neutral Sentiment: Management commentary from the Q4 2025 earnings call provides execution detail on capacity, product mix and margin levers; useful for judging whether targets are achievable but contains typical quarterly nuance rather than new catalysts. Stevanato Group S.p.A. (STVN) Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Analyst/press pieces are urging investors to reassess valuation after the rebound — the stock trades with a relatively high P/E and a mix shift that could justify a premium, but valuation risk remains. Is It Time To Reassess Stevanato Group (STVN) After The Recent Share Price Rebound
• Negative Sentiment: EPS figures were reported inconsistently across outlets (some data sources show a small miss vs one consensus figure, while others report a beat), creating short‑term confusion; additionally FY2026 EPS guidance (0.690–0.730) sits at or slightly below some consensus estimates — a modest downside risk if execution slips. Stevanato Group earnings report on MarketBeat Stevanato Group (STVN) Surpasses Q4 Earnings and Revenue Estimates

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.